DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
13F holders, Q1 2025
Institutional positions in DBV Technologies S.A. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −2 vs. Q4 2024
- Shares held
- 2.47M
- −269.2K (−9.8%) vs. Q4 2024
- Total value
- $16.8M
- +$8.37M (+99.0%) vs. Q4 2024
- New holders
- 3
- 4 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $345.7M |
| Q1 2026 | 71 | $433.6M |
| Q4 2025 | 52 | $302.1M |
| Q3 2025 | 33 | $65.2M |
| Q2 2025 | 29 | $66.2M |
| Q1 2025 | 16 | $16.8M |
| Q4 2024 | 18 | $8.46M |
| Q3 2024 | 24 | $11.3M |
| Q2 2024 | 30 | $13.7M |
| Q1 2024 | 33 | $29.2M |
| Q4 2023 | 40 | $36.6M |
| Q3 2023 | 38 | $60.4M |
| Q2 2023 | 36 | $87.4M |
| Q1 2023 | 34 | $71.3M |
| Q4 2022 | 38 | $68.0M |
| Q3 2022 | 36 | $61.1M |
| Q2 2022 | 38 | $66.8M |
| Q1 2022 | 31 | $32.9M |
| Q4 2021 | 41 | $34.7M |
| Q3 2021 | 51 | $179.8M |
| Q2 2021 | 48 | $243.5M |
| Q1 2021 | 44 | $197.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding DBV Technologies S.A.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 1,461,425 | $9.97M | 0.11% | 00.0% | Unchanged |
| Yiheng Capital Management, L.P. | 656,309 | $4.48M | 1.57% | 00.0% | Unchanged |
| UBS Group AG | 163,487 | $1.11M | 0.00% | +1,111+0.7% | Added |
| Cantor Fitzgerald, L. P. | 95,460 | $651.0K | 0.02% | +95,460 | New |
| Morgan Stanley | 40,271 | $274.6K | 0.00% | −5,450−11.9% | Reduced |
| Nan Fung Group Holdings Ltd | 37,095 | $253.0K | 0.21% | 00.0% | Unchanged |
| Optiver Holding B.V. | 8,347 | $56.9K | 0.00% | +8,311+23,086.1% | Added |
| Rhumbline Advisers | 3,890 | $26.5K | 0.00% | +991+34.2% | Added |
| Federation des caisses Desjardins du Quebec | 425 | $2.90K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 320 | $2.18K | 0.00% | +320 | New |
| Mark Sheptoff Financial Planning, LLC | 300 | $2.05K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 298 | $2.03K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 120 | $818 | 0.00% | +100+500.0% | Added |
| Northwestern Mutual Wealth Management Co | 111 | $757 | 0.00% | 00.0% | Unchanged |
| Curio Wealth, LLC | 1 | $83 | 0.00% | −26−96.3% | Reduced |
| Advisor Group Holdings, Inc. | 11 | $74 | 0.00% | +11 | New |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −286,250−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −32,020−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,650−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −123−100.0% | Sold out |